Home | Prescription Drugs | Holkira Pak

Holkira Pak (Dasabuvir Sodium/Omitasvir/Paritaprevir/Ritonavir)

Type
Drug
Manufacturer
Country
Dosage
Qty
Price(USD)
Type:
Drug:Holkira Pak Tablet
ManufacturerAbbvie
Country:Canada
Dosage:250 mg/12.5 mg/75 mg/50 mg
Qty:28
Price:$19,001.99

Holkira Pak (ombitasvir – paritaprevir – dasabuvir – ritonavir) is a combination of antivirals commonly used alone or in combination with ribavirin to treat chronic hepatitis C, a viral infection of the liver. Ombitasvir, paritaprevir, and dasabuvir directly interfere with the replication of the hepatitis virus, while ritonavir acts only to improve the oral absorption of paritaprevir. The actions of ombitasvir, paritaprevir, and dasabuvir are based on the reduction of hepatitis C virus levels in the body, which aids in the immune system's ability to combat the infection and may aid in liver recovery. Ritonavir is used to raise (or "boost") paritaprevir levels. Holkira Pak does not prevent transmission of the hepatitis C virus through sexual intercourse, or blood contamination, neither does it protect a patient from reinfection with the virus. The product typically contains two tablets: One containing ombitasvir, paritaprevir, and ritonavir, and the other tablet containing dasabuvir.

Manufacturer Information

We currently offer the brand Holkira Pak from Canada by Abbvie. The generic version is not available.

Holkira Pak may cause tiredness, weakness, nausea, mild itching, or difficulty sleeping. If any of these effects persists or gets worse, inform your doctor or pharmacist promptly.

Check with your doctor as soon as possible if you notice any symptoms of liver dysfunction while taking this drug. They may include:
• Nausea;
• Vomiting;
• Diarrhea;
• Loss of appetite;
• Weight loss;
• Yellowing of the skin or whites of the eyes;
• Dark urine;
• Pale stools

Patients may also develop a rare severe allergic reaction to the medication, which initially presents as a rash or mild reaction. Stop taking the medication and see your doctor immediately if you notice signs of an allergic reaction including:
• Abdominal cramps;
• Difficulty breathing;
• Nausea and vomiting;
• Swelling of the face and throat

You should not use Holkira Pak if you have moderate to severely decreased liver function or if you are:
• Allergic to ombitasvir, paritaprevir, ritonavir, dasabuvir or to any of the ingredients of the medication;
• Pregnant and also taking ribavirin

Before you start using this medication, talk to your doctor about your medical history and if you have a heart rhythm disorder, hepatitis B infection or problems with liver function. You should also inform your doctor about all the medications you take including prescription, OTC, herbal supplements and vitamins. There may be a drug interaction between Holkira Pak and other medications. This medication should be used during pregnancy. Consult your doctor if you are breastfeeding.

Blog Post

Can a Vegan Diet Lower Your Risk of Colorectal Cancer?

The content on this page has been supplied to canadianpharmacyking by an independent third party contracted to provide information for our website. canadianpharmacyking relies on these third parties to create and maintain this information and cannot guarantee the medical efficacy, accuracy or reliability of the information that has been provided to us. If you require any advice or information about the drugs on this page, a medical condition or treatment advice, you should always speak to a health professional. Please note that not all products, including any referenced in this page, are shipped by our affiliated Canadian Pharmacy. We affiliate with other dispensaries that ship product to our customers from the following jurisdictions: Canada, New Zealand, Australia, Turkey, Mauritius, India, and the United Kingdom. The items in your order maybe shipped from any of the above jurisdictions. The products are sourced from various countries as well as those listed above. Rest assured, we only affiliate with licensed pharmacies and fulfillment centers that procure products from reliable sources.